Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players- Technavio

NEW YORK, July 14, 2023 /PRNewswire/ -- The vaccine research market size is estimated to grow by USD 17.59 billion from 2022 to 2027 at a CAGR of 9.88%, according to Technavio. The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Technavio report analyzes the market's competitive landscape and offers information on several market vendors including Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Creative Biogene Download a Sample Report Now!

Vaccine research market Insights -

• Vendors: 15+, Including Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Creative Biogene, among others
• Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and vendor landscape; vendor product insights and recent developments; key vendors; and market positioning of vendors
• Segments: End-user (Public and Private), age group (pediatric and adult), and Geography (North America, Europe, Asia, and Rest of World (ROW))

To understand more about the Vaccine research market, request a sample report

Major Drivers - The high prevalence of infectious diseases drives the growth of the vaccine research market. The impact of infectious diseases has often been devastating in developing countries. This is due to the poor healthcare infrastructure, leading to a high number of fatalities, particularly in the pediatric population, and hampering economic growth and development.

As a result of the increasing incidence and prevalence of infectious diseases, vendors are heavily investing in the R&D of vaccines. Furthermore, the need for novel vaccines to prevent several emerging and re-emerging infectious diseases, such as COVID-19, is increasing. Hence, such factors boost the market growth during the forecast period.

Significant Trends - The adoption of AI to speed up the R&D of vaccines is an emerging trend in the market.

Key challenges - The high cost of vaccine research, development, and manufacturing challenges the growth of the market during the forecast period.

Drivers, Trends, and Challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!

The vaccine research market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as future prospects.

Why Buy?

• Add credibility to strategy
• Analyzes competitor's offerings 
• Get a holistic view of the market

Grow your profit margin with Technavio- Buy the Report

What are the key data covered in this vaccine research market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the vaccine research market between 2023 and 2027
• Precise estimation of the size of the vaccine research market and its contribution to the market with a focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the vaccine research market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of vaccine research market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

The porcine vaccine market size is expected to increase by USD 794.67 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.01%. Furthermore, this report extensively covers porcine vaccine market segmentations by product (intravenous, intramuscular, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The increasing prevalence of porcine diseases is notably driving the porcine vaccine market growth.

The global mono vaccine market size is estimated to grow by USD 2.8 billion between 2021 to 2026 accelerating at a CAGR of 5.16%. This mono vaccine market report extensively covers market segmentation by Type (meningococcal vaccine, japanese encephalitis vaccine, hepatitis vaccine, yellow fever vaccine, and others) and Geography (North America, Europe, Asia, and Rest of World (ROW)). The mono vaccine market is experiencing more mergers and acquisitions between companies to develop and sell drugs for infectious disease treatment. 

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Age Group
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global vaccine research market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on global vaccine research market 2017 - 2021 ($ billion)

• 4.2 End-User Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – End-User Segment 2017 - 2021 ($ billion)

• 4.3 Age Group Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Age Group Segment 2017 - 2021 ($ billion)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)

• 6.2 Comparison by End-user 
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user

• 6.3 Public - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Public - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on Public - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on Public - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Public - Year-over-year growth 2022-2027 (%)

• 6.4 Private - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Private - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on Private - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on Private - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Private - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by End-user 
• Exhibit 42: Market opportunity by End-user ($ billion)
• Exhibit 43: Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Age Group

• 7.1 Market segments
• Exhibit 44: Chart on Age Group - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Age Group - Market share 2022-2027 (%)

• 7.2 Comparison by Age Group 
• Exhibit 46: Chart on Comparison by Age Group
• Exhibit 47: Data Table on Comparison by Age Group

• 7.3 Pediatric - Market size and forecast 2022-2027 
• Exhibit 48: Chart on Pediatric - Market size and forecast 2022-2027 ($ billion)
• Exhibit 49: Data Table on Pediatric - Market size and forecast 2022-2027 ($ billion)
• Exhibit 50: Chart on Pediatric - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Pediatric - Year-over-year growth 2022-2027 (%)

• 7.4 Adult - Market size and forecast 2022-2027 
• Exhibit 52: Chart on Adult - Market size and forecast 2022-2027 ($ billion)
• Exhibit 53: Data Table on Adult - Market size and forecast 2022-2027 ($ billion)
• Exhibit 54: Chart on Adult - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Adult - Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by Age Group 
• Exhibit 56: Market opportunity by Age Group ($ billion)
• Exhibit 57: Data Table on Market opportunity by Age Group ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 59: Chart on Market share by geography 2022-2027 (%)
• Exhibit 60: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027 
• Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 UK - Market size and forecast 2022-2027 
• Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.10 China - Market size and forecast 2022-2027 
• Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.11 Canada - Market size and forecast 2022-2027 
• Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 99: Market opportunity by geography ($ billion)
• Exhibit 100: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 101: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 105: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 106: Matrix on vendor position and classification

• 12.3 Abbott Laboratories
• Exhibit 107: Abbott Laboratories - Overview
• Exhibit 108: Abbott Laboratories - Business segments
• Exhibit 109: Abbott Laboratories - Key news
• Exhibit 110: Abbott Laboratories - Key offerings
• Exhibit 111: Abbott Laboratories - Segment focus

• 12.4 Astellas Pharma Inc.
• Exhibit 112: Astellas Pharma Inc. - Overview
• Exhibit 113: Astellas Pharma Inc. - Product / Service
• Exhibit 114: Astellas Pharma Inc. - Key news
• Exhibit 115: Astellas Pharma Inc. - Key offerings

• 12.5 AstraZeneca Plc
• Exhibit 116: AstraZeneca Plc - Overview
• Exhibit 117: AstraZeneca Plc - Product / Service
• Exhibit 118: AstraZeneca Plc - Key news
• Exhibit 119: AstraZeneca Plc - Key offerings

• 12.6 Bavarian Nordic AS
• Exhibit 120: Bavarian Nordic AS - Overview
• Exhibit 121: Bavarian Nordic AS - Product / Service
• Exhibit 122: Bavarian Nordic AS - Key offerings

• 12.7 Bharat Biotech Ltd.
• Exhibit 123: Bharat Biotech Ltd. - Overview
• Exhibit 124: Bharat Biotech Ltd. - Product / Service
• Exhibit 125: Bharat Biotech Ltd. - Key news
• Exhibit 126: Bharat Biotech Ltd. - Key offerings

• 12.8 CanSino Biologics Inc. 
• Exhibit 127: CanSino Biologics Inc. - Overview
• Exhibit 128: CanSino Biologics Inc. - Product / Service
• Exhibit 129: CanSino Biologics Inc. - Key offerings

• 12.9 CSL Ltd.
• Exhibit 130: CSL Ltd. - Overview
• Exhibit 131: CSL Ltd. - Business segments
• Exhibit 132: CSL Ltd. - Key news
• Exhibit 133: CSL Ltd. - Key offerings
• Exhibit 134: CSL Ltd. - Segment focus

• 12.10 Daiichi Sankyo Co. Ltd. 
• Exhibit 135: Daiichi Sankyo Co. Ltd. - Overview
• Exhibit 136: Daiichi Sankyo Co. Ltd. - Product / Service
• Exhibit 137: Daiichi Sankyo Co. Ltd. - Key news
• Exhibit 138: Daiichi Sankyo Co. Ltd. - Key offerings

• 12.11 Emergent BioSolutions Inc. 
• Exhibit 139: Emergent BioSolutions Inc. - Overview
• Exhibit 140: Emergent BioSolutions Inc. - Product / Service
• Exhibit 141: Emergent BioSolutions Inc. - Key news
• Exhibit 142: Emergent BioSolutions Inc. - Key offerings

• 12.12 GlaxoSmithKline Plc
• Exhibit 143: GlaxoSmithKline Plc - Overview
• Exhibit 144: GlaxoSmithKline Plc - Business segments
• Exhibit 145: GlaxoSmithKline Plc - Key news
• Exhibit 146: GlaxoSmithKline Plc - Key offerings
• Exhibit 147: GlaxoSmithKline Plc - Segment focus

• 12.13 Johnson and Johnson Services Inc. 
• Exhibit 148: Johnson and Johnson Services Inc. - Overview
• Exhibit 149: Johnson and Johnson Services Inc. - Business segments
• Exhibit 150: Johnson and Johnson Services Inc. - Key news
• Exhibit 151: Johnson and Johnson Services Inc. - Key offerings
• Exhibit 152: Johnson and Johnson Services Inc. - Segment focus

• 12.14 Merck and Co. Inc.
• Exhibit 153: Merck and Co. Inc. - Overview
• Exhibit 154: Merck and Co. Inc. - Business segments
• Exhibit 155: Merck and Co. Inc. - Key news
• Exhibit 156: Merck and Co. Inc. - Key offerings
• Exhibit 157: Merck and Co. Inc. - Segment focus

• 12.15 Novavax Inc.
• Exhibit 158: Novavax Inc. - Overview
• Exhibit 159: Novavax Inc. - Product / Service
• Exhibit 160: Novavax Inc. - Key offerings

• 12.16 Panacea Biotec Ltd.
• Exhibit 161: Panacea Biotec Ltd. - Overview
• Exhibit 162: Panacea Biotec Ltd. - Product / Service
• Exhibit 163: Panacea Biotec Ltd. - Key offerings

• 12.17 Pfizer Inc.
• Exhibit 164: Pfizer Inc. - Overview
• Exhibit 165: Pfizer Inc. - Product / Service
• Exhibit 166: Pfizer Inc. - Key news
• Exhibit 167: Pfizer Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 168: Inclusions checklist
• Exhibit 169: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 170: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 171: Research methodology
• Exhibit 172: Validation techniques employed for market sizing
• Exhibit 173: Information sources

• 13.5 List of abbreviations 
• Exhibit 174: List of abbreviations 

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio